8-K

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K

     Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

        Date of report (Date of earliest event reported): March 20, 2006


                            INGEN TECHNOLOGIES, INC.
             (Exact name of registrant as specified in its charter)


                Georgia                                88-0429044
          --------------------                    --------------------
     (State or other jurisdiction of                (I.R.S. Employer
      incorporation or organization)             Identification Number)

                                    00028704
                                  ------------
                            (Commission File Number)


              35193 Avenue "A", Suite-C, Yucaipa, California 92399
              -----------------------------------------------------
              (Address of principal executive offices and zip code)

                                 (800) 259-9622
                                 --------------
              (Registrant's telephone number, including area code)

                                 Not Applicable
          (Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):

    [ ] Written communications pursuant to Rule 425 under the Securities Act
        (17 CFR 230.425)

    [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
        CFR 240.14a-12)

    [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
        Exchange Act (17 CFR 240.14d-2(b))

    [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
        Exchange Act (17 CFR 240.13e-4(c))






5.02    Election of Directors; Appointment of Officers

        A) On March 20, 2006, Ingen Technologies, Inc. announced the election of
Scott Sand, Christopher Wirth, Curt Mediema, Yong Sin Khoo, Stephen O'Hara, MD,
and John Finazzo, MD, to the company's Board of Directors. All directors will
serve until the next regularly scheduled annual shareholders' meeting in March
of 2007.

        Dr. Finazzo is a new board member. He is 41 years old. His bio follows:

        Education:

    o   B.A. University of California, Riverside, 1986 (Phi Beta Kappa),
        Bio-Medical Sciences

    o   M.D. University of California, Los Angeles, 1989

    o   Resident in Surgery, UCLA, 1991

    o   Resident Otolaryngology - Head and Neck Surgery New York State
        University, Health Science Center Brooklyn, 1995


Credentials:

    o   Board Certified, American Board of Otolaryngology, 1996

    o   Surgical Staff, Desert Regional Medical Center, 1995 to Present

    o   Surgical Staff, Eisenhower Medical Center, 1995 to Present

    o   Section Chief - Division of Otolaryngology, Eisenhower Medical Center

    o   Surgical Staff, John F. Kennedy Medical Center, 1996 to Present


Experience:

Dr. Finazzo graduated from UCLA School of Medicine in 1989. He completed a
two-year Surgical Internship at UCLA Center for Health Science in 1991. He then
completed residency in Otolaryngology - Head and Neck Surgery at the State
University of New York Health Science Center, Brooklyn in 1995. He is Board
Certified in Otolaryngology.

Dr. Finazzo has been in private practice in the Palm Springs area for eight
years. He resides in Palm Springs with his wife of 15 years. He is active in
clinical research for the treatment of acute sinusitis.

        B) On March 20, 2006, the Ingen Technologies, Inc. Board of Directors
re-appointed Scott Sand to serve as Chief Executive Officer and Chairman and Tom
Neavitt to serve as Secretary and Chief Financial Officer.

        C) The press release, mentioned above, is included herewith as an
Exhibit.


                                       2



                                   SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

Dated:  March 24, 2006              Ingen Technologies, Inc.


                                    By: /s/ Scott R. Sand
                                        -------------------------------------
                                        Scott R. Sand,
                                        Chief Executive Officer and Chairman



TABLE OF EXHIBITS
(All Exhibits have been properly signed by the parties.
Original agreements are filed in our offices)


      EXHIBIT NO.              DESCRIPTION

         99.1         Press Release of March 20, 2006.


                                       3

EX-99

Exhibit 99.1

Calimesa, CA - March 20, 2006 -- Ingen Technologies, Inc. (OTC: IGTG), a medical
device manufacturer of OxyAlert(TM), OxyView, and Secure Balance(TM), announced
today the election of John J. Finazzo, MD to the company's Board of Directors.

Dr. Finazzo graduated from UCLA School of Medicine in 1989. He completed a
two-year Surgical internship at UCLA Center for Health Science in 1991. He then
completed residency in Otolaryngology - Head and Neck Surgery at the State
University of New York Health Science Center, Brooklyn in 1995. He is Board
Certified in Otolaryngology and has been in private practice in the Palm
Springs-California area for eight years. He resides in Palm Springs with his
wife of 15 years. He is active in clinical research and lectures on vestibular
function and balance disorders.

"Dr. Finazzo and I have been business associates since 2000 when we were
lecturing together on Balance & Fall Prevention. He is an excellent physician
and very experienced with vestibular disorders. We are very pleased to have Dr.
Finazzo on our Board of Directors. We expect him to provide valuable
contributions to our product lines and corporate advancement," said Scott Sand,
Chairman & CEO.

Scott Sand, Christopher Wirth, Curt Mediema, Yong Sin Khoo and Stephen O'Hara,
MD were re-elected to the Board of Directors. All of our directors are slated to
serve until the next regularly scheduled annual shareholders' meeting in March
of 2007.


ABOUT INGEN TECHNOLOGIES, INC.

Ingen Technologies, Inc. is a public company trading under NASDAQ OTC:IGTG,
which has been in business since 1999. IGTG is a medical device manufacturer and
a growth-oriented company that owns US patent(s), trademarks, and proprietary
medical products. Ingen Technologies, Inc. ("Ingen" or the "Company"), a Georgia
Corporation, was formed as a result of a reverse merger in March 2004 whereby
Ingen became a publicly-owned company and commenced trading in the
Over-The-Counter market on the Pink Sheets. Ingen (GA) is a holding company
which owns or has intellectual property rights to certain proprietary devices
which primarily provide diagnostic and safety features to health practitioners
and patients. Operations are conducted through a 100%-owned subsidiary, Ingen
Technologies, Inc. of Nevada, which has been in business since 1999 when
Chairman/CEO Scott R. Sand founded it. The principal executive office is in
Yucaipa, CA, northeast of Los Angeles.

The Company's flagship product is OxyAlert(TM), a second-generation design of
the Company's BAFI(TM) product line. Both of these products have been issued two
US Patents: Patent No. 6,137,417 issued on October 24, 2000 and Patent No.
6,326,896 issued on December 4, 2001. Both of these products are low-oxygen
safety warning devices used on remote oxygen cylinders for patients, commercial
aircraft, military transport, and fire and safety equipment. OxyAlert(TM)
technology encompasses the use of digital sensing and RF frequency transfer so
that care givers can access a hand-held remote to monitor the actual oxygen
level of any oxygen cylinder at a reasonable distance.

The newest product, OxyView, has a patent pending, and is a pneumatic gauge that
provides visual safety warning of oxygen flow for patients in the hospital,
surgical room, outpatient therapy, nursing homes and emergency response
facilities. This product enhances the safety, assurance and accuracy of patients
being administered oxygen from any source. OxyView(TM) is a lightweight
pneumatic gauge that is attached to the oxygen tubing just below the neck. It
informs the nursing staff of the oxygen flow rate near the patient. It could
quickly inform the physician or technician of any leak or inaccuracy between the
delivery source and the patient.


                                       1



The Secure Balance(TM) product is a private-label product that includes a
vestibular function testing system and balance therapy system. The vestibular
function testing system is manufactured by Interacoustics LTD. in Denmark and is
referred to as the VNG. The balance therapy system is manufactured by
SportKAT(R), Inc. in San Diego, California. The Secure Balance(TM) program
provides equipment, education and training about balance and fall prevention to
physicians and clinicians worldwide.

The Pure Produce product is a continuing research & development program
currently under design. This program uses hydroponics technology to grow various
plants without the use of soil, fertilizer and water consumption. The Company
anticipates entering the nutriceutical and pharmaceutical markets over the next
two years.

"Our team of professionals has developed our medical products for the
ever-increasing elderly population. Our products are superior to any of our
competition and they allow for effective medical product availability to
seniors, and at the same time the increasing senior population allows for a
steady growth in sales and profits," said Scott Sand, CEO & Chairman of Ingen
Technologies.

For more information, visit  www.ingen-tech.com
                             ------------------

Investor Relations Contact:  Scott R. Sand, C.E.O & Chairman
Ingen Technologies, Inc. - Administrative Office
35193 Avenue "A", Suite-C
Yucaipa, California 92399
Phone: (800) 259-9622 or (909) 790-7180
Fax: (800) 777-1186 or (909) 795-6340
Email: Info@ingen-tech.com
A Member of the Better Business Bureau
A Member of the Chamber of Commerce
     A Licensed Business in the City of Yucaipa

Safe Harbor for Forward-Looking Statements: This news release includes
forward-looking statements that are made pursuant to "Safe Harbor" provisions of
the Private Securities Litigation Reform Act of 1995. While these statements are
made to convey to the public the company's progress, business opportunities and
growth prospects, readers are cautioned that such forward-looking statements
represent management's opinion. Whereas management believes such representations
to be true and accurate based on information and data available to the company
at this time, actual results may differ materially from those described. The
company's operations and business prospects are always subject to risk and
uncertainties. Important factors that may cause actual results to differ will be
set forth in the company's periodic filings with the U.S. Securities and
Exchange Commission.


                                       2